{"id":"NCT05093478","sponsor":"The University of Texas Health Science Center, Houston","briefTitle":"The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population","officialTitle":"The Prevalence of Local IgE Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-09-10","primaryCompletion":"2023-11-30","completion":"2023-11-30","firstPosted":"2021-10-26","resultsPosted":"2024-12-20","lastUpdate":"2024-12-20"},"enrollment":28,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Intranasal capsaicin","otherNames":[]},{"type":"DRUG","name":"topical lidocaine","otherNames":[]}],"arms":[{"label":"Treatment","type":"EXPERIMENTAL"}],"summary":"The purpose of this study to determine the therapeutic response of non-allergic rhinitis patients that have been subtyped as non-allergic rhinitis with local IgE elevation or non-allergic rhinopathy to intranasal capsaicin based on visual analog scale and optical rhinometry, to determine the prevalence of non-allergic rhinitis with local IgE elevation in this study's cohort of patients with non-allergic rhinitis identified by rhinitis history and negative skin testing for allergic rhinitis, and to determine the change, if any, in intranasal IgE levels after capsaicin treatment.","primaryOutcome":{"measure":"Runny Nose as Measured by the Visual Analog Scale (VAS) at Baseline","timeFrame":"baseline","effectByArm":[{"arm":"Treatment","deltaMin":6.07,"sd":2.41}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":28},"commonTop":[]}}